EA200400699A1 - 3,4-дизамещенные, 3,5-дизамещенные и 3,4,5-замещенные пиперидины и пиперазины - Google Patents
3,4-дизамещенные, 3,5-дизамещенные и 3,4,5-замещенные пиперидины и пиперазиныInfo
- Publication number
- EA200400699A1 EA200400699A1 EA200400699A EA200400699A EA200400699A1 EA 200400699 A1 EA200400699 A1 EA 200400699A1 EA 200400699 A EA200400699 A EA 200400699A EA 200400699 A EA200400699 A EA 200400699A EA 200400699 A1 EA200400699 A1 EA 200400699A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- designed
- beta
- piperasins
- alzheimer
- amyloid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Изобретение относится к замещенным пиперидиновым, пиперазиновым, морфолиновым и тиоморфолиновым соединениям, применимым для лечения болезни Альцгеймера, и, в частности, к соединениям, способным ингибировать бета-секретазу, фермент, который расщепляет белок-предшественник амилоида с образованием пептида амилоида бета (А-бета), основного компонента амилоидных бляшек, которые обнаруживаются в головном мозгу пациентов, страдающих болезнью Альцгеймера.Отчет о международном поиске был опубликован 2003.07.10.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33270801P | 2001-11-19 | 2001-11-19 | |
US38316702P | 2002-05-24 | 2002-05-24 | |
PCT/US2002/037037 WO2003043987A2 (en) | 2001-11-19 | 2002-11-19 | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200400699A1 true EA200400699A1 (ru) | 2004-12-30 |
Family
ID=26988352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400699A EA200400699A1 (ru) | 2001-11-19 | 2002-11-19 | 3,4-дизамещенные, 3,5-дизамещенные и 3,4,5-замещенные пиперидины и пиперазины |
Country Status (21)
Country | Link |
---|---|
US (1) | US7338965B2 (ru) |
EP (1) | EP1448200A2 (ru) |
JP (1) | JP2005514362A (ru) |
KR (1) | KR20050044533A (ru) |
AP (1) | AP2004003052A0 (ru) |
AU (1) | AU2002360403A1 (ru) |
BR (1) | BR0214295A (ru) |
CA (1) | CA2467749A1 (ru) |
CO (1) | CO5580743A2 (ru) |
EA (1) | EA200400699A1 (ru) |
GE (1) | GEP20074045B (ru) |
HR (1) | HRP20040550A2 (ru) |
IL (1) | IL162079A0 (ru) |
IS (1) | IS7271A (ru) |
MX (1) | MXPA04004772A (ru) |
NO (1) | NO20042580L (ru) |
NZ (1) | NZ533158A (ru) |
OA (1) | OA12812A (ru) |
RS (1) | RS54204A (ru) |
TN (1) | TNSN04088A1 (ru) |
WO (1) | WO2003043987A2 (ru) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
JP2008535863A (ja) | 2005-04-08 | 2008-09-04 | コメンティス,インコーポレーテッド | β−セクレターゼ活性を阻害する化合物およびその使用方法 |
EP1816122A3 (en) * | 2006-01-19 | 2007-09-19 | Speedel Experimenta AG | 3,4,5-substituted piperidines as therapeutic compounds |
AU2007262635B2 (en) | 2006-06-23 | 2014-09-11 | Adc Therapeutics Sa | Polynucleotides and polypeptide sequences involved in cancer |
KR100679869B1 (ko) * | 2006-10-27 | 2007-02-07 | 한국기계연구원 | Dpf시스템용 플라즈마 반응기와 이를 이용한 입자상물질의 저감 장치 |
WO2008036316A2 (en) * | 2006-09-21 | 2008-03-27 | Merck & Co., Inc. | Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
KR100838645B1 (ko) * | 2006-09-28 | 2008-06-16 | 한국화학연구원 | 베타-세크리테아제 활성을 억제하는 피페리딘 화합물 |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
AU2008220785B2 (en) | 2007-03-01 | 2013-02-21 | Vivoryon Therapeutics N.V. | New use of glutaminyl cyclase inhibitors |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
KR100894713B1 (ko) * | 2007-10-08 | 2009-04-24 | 한국화학연구원 | 베타-세크리테아제의 활성을 저해하는 아릴피페라진이 치환된 피페리딘 유도체 또는 이의 약제학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 신경퇴행성 질환의 예방 또는 치료용 조성물 |
AU2009321508B2 (en) | 2008-11-03 | 2015-03-12 | Adc Therapeutics Sa | Antibodies that specifically block the biological activity of a tumor antigen |
PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
BR112013025198A2 (pt) | 2011-03-31 | 2018-12-04 | Alethia Biotherapeutics Inc. | anticorpos contra antígeno 1 associado a rim e fragmentos de ligação a antígeno do mesmo |
PL2802351T3 (pl) | 2012-01-09 | 2019-11-29 | Adc Therapeutics Sa | Środki do leczenia potrójnie negatywnego raka piersi |
PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992441A (en) * | 1972-12-26 | 1976-11-16 | Pfizer Inc. | Sulfamylbenzoic acids |
US4248876A (en) * | 1977-01-08 | 1981-02-03 | John Wyeth & Brother Ltd. | Piperidine derivatives |
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
DE3640475A1 (de) * | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
US4997836A (en) * | 1988-11-11 | 1991-03-05 | Takeda Chemical Industries, Ltd. | Trisubstituted piperazine compounds, their production and use |
US5708004A (en) * | 1990-11-19 | 1998-01-13 | Monsanto Company | Retroviral protease inhibitors |
US5843946A (en) * | 1992-08-25 | 1998-12-01 | G.D. Searle & Co. | α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
US5475138A (en) * | 1994-07-07 | 1995-12-12 | Pharm-Eco Laboratories Incorporated | Method preparing amino acid-derived diaminopropanols |
DK0863875T3 (da) * | 1995-09-07 | 2003-12-01 | Hoffmann La Roche | Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser |
JP2001510474A (ja) | 1997-02-04 | 2001-07-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | カテプシンdのナノモルの非ペプチド阻害剤 |
AU9740998A (en) * | 1997-09-08 | 1999-03-29 | F. Hoffmann-La Roche Ag | Piperidine derivatives against malaria |
CA2306477A1 (en) * | 1997-11-05 | 1999-05-20 | Neurosearch A/S | Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
DE69928226T8 (de) * | 1998-01-21 | 2006-10-19 | Millennium Pharmaceuticals, Inc., Cambridge | Chemokin rezeptor antagonisten und verwendung |
GB9810671D0 (en) * | 1998-05-18 | 1998-07-15 | Pfizer Ltd | Anti-pruritic agents |
IL140770A0 (en) * | 1998-07-10 | 2002-02-10 | Astrazeneca Ab | N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
US6274735B1 (en) * | 1998-08-10 | 2001-08-14 | Hoffmann-La Roche Inc. | Process and intermediates for preparation of substituted piperidines |
JP2002526528A (ja) * | 1998-10-07 | 2002-08-20 | ジョージタウン ユニヴァーシティー | 単量体およびニ量体の複素環、ならびにその治療的使用 |
GB9904786D0 (en) * | 1999-03-02 | 1999-04-28 | Merck Sharp & Dohme | Therapeutic agents |
CA2438318A1 (en) * | 2001-02-16 | 2002-08-29 | Aventis Pharmaceuticals Inc. | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
US20060079533A1 (en) * | 2001-03-23 | 2006-04-13 | Nieman James A | Methods of treating alzheimer's disease |
WO2002088101A2 (en) * | 2001-04-27 | 2002-11-07 | Vertex Pharmaceuticals Incorporated | Inhibitors of bace |
-
2002
- 2002-11-19 KR KR1020047007631A patent/KR20050044533A/ko not_active Application Discontinuation
- 2002-11-19 WO PCT/US2002/037037 patent/WO2003043987A2/en active Application Filing
- 2002-11-19 AU AU2002360403A patent/AU2002360403A1/en not_active Abandoned
- 2002-11-19 EP EP02795653A patent/EP1448200A2/en not_active Withdrawn
- 2002-11-19 GE GE5634A patent/GEP20074045B/en unknown
- 2002-11-19 CA CA002467749A patent/CA2467749A1/en not_active Abandoned
- 2002-11-19 OA OA1200400289A patent/OA12812A/en unknown
- 2002-11-19 AP APAP/P/2004/003052A patent/AP2004003052A0/en unknown
- 2002-11-19 JP JP2003545624A patent/JP2005514362A/ja active Pending
- 2002-11-19 MX MXPA04004772A patent/MXPA04004772A/es not_active Application Discontinuation
- 2002-11-19 NZ NZ533158A patent/NZ533158A/en unknown
- 2002-11-19 EA EA200400699A patent/EA200400699A1/ru unknown
- 2002-11-19 IL IL16207902A patent/IL162079A0/xx unknown
- 2002-11-19 US US10/299,746 patent/US7338965B2/en not_active Expired - Fee Related
- 2002-11-19 RS YU54204A patent/RS54204A/sr unknown
- 2002-11-19 BR BR0214295-3A patent/BR0214295A/pt not_active IP Right Cessation
-
2004
- 2004-05-19 TN TNP2004000088A patent/TNSN04088A1/en unknown
- 2004-05-19 IS IS7271A patent/IS7271A/is unknown
- 2004-05-26 CO CO04048699A patent/CO5580743A2/es not_active Application Discontinuation
- 2004-06-16 HR HR20040550A patent/HRP20040550A2/xx not_active Application Discontinuation
- 2004-06-18 NO NO20042580A patent/NO20042580L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GEP20074045B (en) | 2007-02-26 |
MXPA04004772A (es) | 2005-06-06 |
NZ533158A (en) | 2006-09-29 |
AP2004003052A0 (en) | 2004-06-30 |
OA12812A (en) | 2006-07-10 |
WO2003043987A3 (en) | 2003-07-10 |
AU2002360403A1 (en) | 2003-06-10 |
WO2003043987A2 (en) | 2003-05-30 |
EP1448200A2 (en) | 2004-08-25 |
JP2005514362A (ja) | 2005-05-19 |
CO5580743A2 (es) | 2005-11-30 |
NO20042580L (no) | 2004-08-09 |
IS7271A (is) | 2004-05-19 |
US7338965B2 (en) | 2008-03-04 |
US20040034031A1 (en) | 2004-02-19 |
HRP20040550A2 (en) | 2006-11-30 |
BR0214295A (pt) | 2004-11-09 |
RS54204A (en) | 2006-12-15 |
KR20050044533A (ko) | 2005-05-12 |
IL162079A0 (en) | 2005-11-20 |
TNSN04088A1 (en) | 2006-06-01 |
CA2467749A1 (en) | 2003-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200400699A1 (ru) | 3,4-дизамещенные, 3,5-дизамещенные и 3,4,5-замещенные пиперидины и пиперазины | |
EA200400162A1 (ru) | N-(3-амино-2-гидроксипропил)замещенные алкиламидные соединения | |
MXPA04000140A (es) | Derivados de beta-hidroxiamina utiles en el tratamiento de enfermedad de alzheimer. | |
KR960704839A (ko) | β-아밀로이드 단백질 생성 억제제(Inhibitors of β-amyloid protein production) | |
DE60219917D1 (de) | Naphtoquinone derivate als inhibitoren von tau aggregation zur behandlung von alzheimer's und verbundenen neurodegenerativen erkrankungen | |
EA200201247A1 (ru) | Соединения для лечения болезни альцгеймера | |
TW200420550A (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
EA200301216A1 (ru) | Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания | |
EP1841426A4 (en) | TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
TR200100377T2 (tr) | Aß Protein üretimi inhibitörleri olarak sukinoilamino laktamlar. | |
NO20021691L (no) | Benzodiazepinderivater | |
ATE455763T1 (de) | Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit | |
ATE396174T1 (de) | Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
TW200502221A (en) | Novel lactams and uses thereof | |
NO20011891D0 (no) | Anvendelse av radioligander for screening av inhibitorer av amyloid-<beta>-peptid produksjon | |
DE60210614D1 (de) | Für die behandlung von alzheimer krankheit geeignete makrocyclen | |
BR0011728A (pt) | Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide | |
MY139368A (en) | Novel cyclohexyl sulphones | |
DE602004026597D1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen | |
ATE553114T1 (de) | Verbindungen zur verminderung der aggregation von amyloid-beta-peptid | |
BR0112123A (pt) | Composto | |
EA200500382A1 (ru) | Соединения тиазола для лечения нейродегенеративных расстройств | |
AR022292A1 (es) | Succinoilamino benzodiazepinas como inhibidoras de la produccion de proteinas a beta |